Exhibition review | The 6th BIONNOVA BioPharma Innovators Summit & Expo Successfully Concluded at Shanghai Science Hall on April 9-10, 2025
Symposium Highlights
The summit comprehensively addressed critical topics across biopharmaceutical R&D and manufacturing, including:
Therapeutics Development: Antibody drugs, antibody-drug conjugates (ADCs), small molecule drugs, chemical drugs, and peptide therapeutics.
Biologics Manufacturing: CMC strategies for biologics, process optimization, and quality control methodologies.
Advanced Therapies: Cutting-edge advancements in cell therapy, gene therapy, and nucleic acid-based CGT technologies.
Through keynote presentations, panel discussions, and expert dialogues, industry leaders and academic pioneers shared actionable insights to address current and future challenges in biopharma innovation.
Cellgene Bioscience's Exhibition Highlights
As a featured exhibitor at the Bio-Analytical Technology Forum, Cellgene Bioscience showcased its comprehensive solutions:
Residual Analysis Systems: Host Cell Protein (HCP) and Host Cell DNA (HCD) detection kits.
Reagent Portfolio: High-purity recombinant proteins for quality control.
Rapid Testing Platforms: Singleplex and Multiplex Lateral Flow Strips for in-process monitoring.
Our technical team engaged in-depth discussions with attendees, receiving significant attention for these ISO-certified products and GMP-compliant services.
Our Commitment
Cellgene Bioscience remains committed to advancing quality-centric research for pharmaceutical clients. By delivering robust analytical solutions and empowering biopharmaceutical innovation, we steadfastly support the global development of life-saving biologics.
Acknowledgments
We extend our sincere gratitude to all participants for your engagement and trust. Your collaboration drives our progress. Join us again at upcoming industry events to explore new frontiers in biopharma excellence!
